Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week3.45%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-1.11%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter8.93%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y38.24%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year85.40%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range123.52 - 244.98 Perf YTD25.68%
Dividend2.10 P/FCF- EPS past 5Y- ROI- 52W High-4.44% Beta-
Dividend %0.90% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low89.52% ATR6.20
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)62.83 Volatility2.31% 3.11%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.55 Prev Close233.44
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume1.01M Price234.10
Recom- SMA205.27% SMA503.72% SMA20023.62% Volume557,353 Change0.28%
May-21-15 06:21PM  Your first trade for Friday at CNBC
05:58PM  Final Trade: CHL, GPRO, XBI, & URBN
May-20-15 04:25PM  'Don't Give Up On Biotech Yet,' Says This CFA
01:02PM  Heres your only safe bet in this sickly stock market at MarketWatch
May-19-15 06:54PM  China ETFs Power Ahead In 2015; Gold, Silver Get Shine Back at Investor's Business Daily
06:37PM  Your first trade for Wednesday at CNBC
May-15-15 05:15PM  Biotech movers: JNJ & BLUE
May-11-15 10:27PM  How to plan your next conviction trade
May-07-15 05:35PM  Pisani: Markets shrug at big week of biotech IPOs at CNBC
May-06-15 05:10PM  Biotech Sector: Support Levels To Watch
01:00PM  More Biotech Deal-Making Lifts a few ETFs
May-05-15 05:58PM  Its time to start talking about a biotech correction
May-04-15 06:14PM  Your first trade for Tuesday, May 5 at CNBC
May-03-15 06:09PM  The Best (And Worst) ETFs Of Last Week Amid Social Media's Collapse
Apr-30-15 10:44PM  Busted biotechs: by the numbers
11:22AM  No Pain, No Gain
Apr-28-15 02:45PM  A Tough Spot for Biotech ETFs
07:28AM  Bio-Techs under Pressure (Again) Try the Swordfish - Palermo Style
Apr-27-15 03:32PM  What's wrong with healthcare and biotech at CNBC -5.52%
Apr-21-15 11:35AM  Will Amgen Earnings Shape Biotech for the Rest of 2015? at 24/7 Wall St.
08:20AM  Biotech ETF Run not Over Yet, Says Analyst
Apr-07-15 02:00PM  Halftime's hottest trades today: BTU, FB, JPM & XBI
12:58PM  Top trades for the 2nd half: AA, XBI, VLO & WTI
11:10AM  Bio Tech- Support test in play after large reversal pattern
Apr-03-15 03:06PM  How Actavis Generics Drive Revenues
Apr-02-15 10:00AM  Dyax HAE Drug Result Fuels Three Biotech ETFs - ETF News And Commentary
Apr-01-15 02:24PM  Don't get duped: April Fools' Day trades to go at CNBC
01:50PM  This Sector Is Dominating The IPO Market In 2015
12:58PM  April Fools' trades: Shake Shack, Delta & more
11:40AM  Cashin says: Unidentified trade takes S&P down to 2,033
11:06AM  How Actavis Has Emerged through Mergers and Acquisitions
11:03AM  Biogen Idec: Survey Says at
11:00AM  A Must-See Biotech ETF Chart
09:30AM  The Top-Performing Biotech Stock During a Sizzling First Quarter at TheStreet
Mar-31-15 05:38PM  Strange close in some ETFs Tuesday at CNBC
03:11PM  Biotech -Monthly reversal pattern in play at resistance
12:57PM  Biotech ETFs in Focus after a Choppy Week - ETF News And Commentary
12:30PM  An ETF That can Quiet Biotech Boo Birds
11:30AM  Bankrupt Introgen Seeks Reincarnation IPO in Biotech Bubble at TheStreet
07:53AM  How bubbles are blown: Biotech edition
Mar-30-15 03:07PM  Why Gilead Stock Could Rise
Mar-27-15 02:18PM  S&P Capital IQ: Diversified Health-Care ETFs for Biotech Lovers at
Mar-26-15 05:30PM  Biotech's rough ride over?
12:32PM  What You Need To Know About This Boom: Our Q&A With A Biotech Expert
10:00AM  Sell-Off in Biotech, Semiconductor ETFs: A Nice Entry Point? - ETF News And Commentary
08:17AM  Topping patterns in the hottest of the hot
07:17AM  Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing at TheStreet
Mar-25-15 05:28PM  Biotech's biggest threat -5.39%
04:16PM  An Ugly Day on Wall Street
02:13PM  Top trades before the closing bell at CNBC
01:02PM  Market selloff: Biggest gainers decline
Mar-24-15 11:26AM  White hot Biotech ETF creates bearish wick at resistance
Mar-23-15 03:37PM  Signs of Froth in the Biotech Sector
12:31PM  Analyst says Biogen has been 'wild-fun,' but it's time to take a break
12:24PM  Are Biotechs the New Dot-coms?
12:21PM  SunTrust Names Eli Lilly, Merck, Bristol-Myers as 'Favorite' Pharma Firms
Mar-20-15 05:06PM  Biggest risk to the biotech boom
04:27PM  Biotech bulls take charge
02:40PM  Triple-Leveraged Biotech ETFs Could be Coming Soon ETF Trends
10:30AM  Direxion Plans Two Triple-Leveraged Biotech ETFs - ETF News And Commentary
10:06AM  Analysts are going crazy for this biotech company after results from an Alzheimer's trial
Mar-19-15 04:57PM  Not So Fast, Mr. Value
02:26PM  Stocks sold off on Thursday except for the one sector people are calling a bubble
Mar-17-15 05:59PM  Biotech, Small-Cap ETFs Stand Out Among March Winners at Investor's Business Daily
10:00AM  3 ETFs for a Green Portfolio on St. Patrick's Day - ETF News And Commentary
Mar-16-15 11:45PM  Biotech is one of the best performing sectors of the decade and its still hitting all-time highs
11:24PM  Biotech Is One Of The Best Performing Sectors Of The Decade, And Its Still Hitting All-Time Highs
09:30AM  Zacks Investment Ideas feature highlights: Biogen, Amgen, SPDR S&P Biotech ETF, BioShares Biotechnology Clinical Trials Fund and ProShares Ultra Nasdaq Biotechnology ETF - Press Releases
Mar-13-15 12:02PM  3 Biotech ETFs Crushing the Market in 2015 - ETF News And Commentary
Mar-12-15 09:25AM  The Biotech Bubble Debate: Solid Science vs. Sky-High Valuations at TheStreet
Mar-11-15 11:11AM  Biotech ETFs Head to Head: XBI Vs. FBT - ETF News And Commentary
Mar-09-15 02:34PM  Three Reasons to Fear Biotech Stocks Right Now at
Mar-04-15 05:30PM  Orexigen soars on drug data
08:44AM  The only 5 investments you need to own at MarketWatch
Feb-27-15 11:19AM  3 ETFs Surging at Start of 2015 - ETF News And Commentary
Feb-25-15 03:06PM  The Best Biotech ETF Isn't Always The Biggest Benzinga
Feb-23-15 05:00PM  Trading tech & biotech: 8 plays on 2 hot sectors
Feb-19-15 05:27PM  Who can beat the 'superbug'?
Feb-09-15 05:30PM  Regulus joins the race to cure Hep C
Feb-05-15 11:30AM  Biotechs Walking a Fine Line
Feb-04-15 05:46PM  Best biotech plays CNBC
12:37PM  Gilead Dislodges a Brick in the Biotech Wall of Worry Yahoo Finance Contributors
Feb-02-15 07:03AM  Biotech Stocks Climb Wall of Worry in January Yahoo Finance Contributors
Jan-30-15 05:13PM  Intercept absolutely a buy: Pro CNBC
07:05AM  Reinventing pharma's next big frontier: Pro CNBC
Jan-20-15 05:52PM  SPDR ETFs: Why Is State Street's Nick Good Excited About 2015? at Investor's Business Daily
Jan-14-15 06:39PM  3 Sectors To Beat: Health, Tech and Industrials at Investor's Business Daily
Jan-13-15 01:23PM  The Poster Child For Risk and Reward Yahoo Finance Contributors
10:19AM  Allow Me To Introduce You To Yahoo Finance Contributors
Jan-12-15 05:00PM  11 ways to play biotech CNBC
Jan-05-15 04:17PM  New Year, New Biotech Stock Offerings -- Lots of 'Em Yahoo Finance Blogs
09:43AM  2015 Biotech Sector Outlook: Bullish but be Wary About Drug Pricing Yahoo Finance Blogs
Dec-31-14 05:31PM  Biotech dips mid-year, then you buy: Pro CNBC
Dec-29-14 10:13AM  Best and worst performing ETFs this year at CNBC
09:36AM  Best & worst ETFs in 2014 CNBC
Dec-23-14 02:35PM  Biotech Stocks Sell Off, ETFs Fall Over 5% Benzinga -5.16%
11:17AM  Biotech Bull Markets and Billion-Dollar Valuations Yahoo Finance Blogs
Dec-21-14 06:32PM  Momentum, Thy Name is Healthcare? Yahoo Finance Contributors
Dec-17-14 07:42AM  Bio-Twitter Sentiment Favors European Orexigen Obesity Pill Approval Yahoo Finance Blogs
Dec-16-14 10:21AM  Viekirax/Exviera vs. Harvoni: Clash of the Hep C Drugs 2015 Yahoo Finance Blogs
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.